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The effects of Rhein and Thymoquinone on obesity and
diabetes in diet-induced obese mice.
Emily Martell, Cameron Picard, and Dr. Angela Slitt
Department of Biomedical and Pharmaceutical Sciences, College Of Pharmacy
University of Rhode Island, Kingston, RI 02881

Introduction

•
•
•
•

There are differences in body weight, FBG, and GTT between the
mice feed a HFD and LFD as expected
The body weights, FBG, and GTT of the groups dosed with rhein
compared with the groups dosed with the vehicle CO show little
differences
The body weights and GTT of the groups dosed with TQ
compared with the groups dosed with the vehicle CO show little
differences
There is a slight difference between the FBG of the HFD group
dosed with TQ compared with the HFD group dosed with the
vehicle CO. Which may be an indication that TQ may lower blood
sugar but more studies need to be conducted and this group is
also missing from the GTT data due to unforeseen circumstances

Figure 1. Changes in average body weights in grams
throughout the 69 days of dosing within the treatment groups.

Future Studies
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Figure 2. Fasting
blood glucose
(mg/dL) of different
treatment groups
measured at day 23
of dosing.
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Materials and Methods
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Blood, liver, kidneys, skeletal muscle, adipose tissue, small
intestine, and colon tissues were collected a further analysis
should be conducted in these tissues such as a Glycated
hemoglobin (A1c or HbA1c) measurement from the blood tissue
which
would
identify
the
average
plasma
glucose
concentration over a prolonged period of time.
Further analysis of the tissues after homogenization, which will
break apart cells so protein expression can be analyzed would be
helpful to determine if the natural products had an effect on
mechanisms of obesity and diabetes.
• Western blotting of LXR, PPARα, PPARγ and RXR would be
useful to see if Rhein or TQ had an effect on these nuclear
receptor that control energy metabolism.
• Western blotting of IRS-1, GLUT2, GLUT4 and SREBP-1c
would be useful to see other mechanisms of glucose and lipid
regulation by transporters and transcription receptors.
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Natural product extracts and chemicals isolated from natural products (e.g. plants,
berries, seeds) have been commonly used in various types of traditional
medicines. In addition, some drugs on the market today have been derived from
natural product sources. The purpose of our study was to evaluate two natural
products, Rhein and Thymoquinone, as potential anti-diabetic and anti–obesity
agents. According to the Center for Disease Control (CDC), the number of people
in the US diagnosed with diabetes has increase from 11.9 million people in the
year 2000 to 20.8 million people in the year 2011. Rhein is a natural compound and
a major component of Rheum palmatum, or Rhubarb. It has been used in Chinese
medicine to treat constipation, gastrointestinal hemorrhage, ulcers as well as
metabolic disorders such as diabetes. Recently, Rhein had been shown to improve
non-alcoholic fatty liver disease (NAFLD) at does of 150 mg/Kg/day in diet induced
obese mice through reducing body fat, improving serum lipid and glucose
metabolism, and decreasing liver lipids, and reversing hepatic steatosis (Sheng et
al., 2011). Rhein has also been shown to bind to and effect the Liver X receptors
(LXRs) which play important roles in regulating cholesterol homeostasis, and lipid
and energy metabolism. (Sheng et al., 2012). Thymoquinone (TQ) is a compound
found in the plant Nigella sativa, or black cumin and has been documented to
exhibit anti-diabetic, anti-obesity, hypotensive and hypo-lipidemic properties in
human and animal studies. (Razavi and Hosseinzadeh, 2014). Extracts from
Nigella sativa significantly increased hepatic and intestinal apolipoprotein A-I
which is a major protein component of high density lipoprotein (HDL) secretion.
The extract also induced peroxisome proliferator-activated receptor alpha (PPARα)
expression by 9-fold and retinoid X receptor alpha (RXRα) expression by 2.5-fold.
(Haas et al., 2014). The PPARα and RXRα nuclear receptors play and important
role in regulating major lipid metabolism proteins. The purpose of our study was
to evaluate whether daily administration of Rhein or TQ could improve obesityinduced diabetes in mice. First, male C57BL/6 mice that were 6 weeks of age were
fed a low fat diet (10% kcal, LFD) or a high fat diet (60% kCal, HFD) for 12 weeks.
Over the twelve-week period, body weight, fasting blood glucose and glucose
tolerance were determined to assess whether the high fat diet could induce a
diabetic condition. Starting from week 12, mice were administered canola oil
vehicle (CO, 5 ml/kg), Rhein (20 mg/kg, 5 ml/kg in CO), or TQ (1 mg/kg, 5 ml/kg)
daily. After three weeks of dosing the Rhein and TQ doses were increased to
Rhein (50 mg/kg, 2.5 ml/kg) and TQ (10 mg/kg, 2.5 ml/kg). There were six groups of
mice in this study, with the following groups: i) LFD + CO, ii) LFD + Rhein, iii) LFD
+ TQ, iv) HFD + CO, v) HFD + Rhein, vi) HFD + TQ. Body weight and food
consumption were measured daily. At periodic points throughout the study,
fasting blood glucose (FBG) and glucose tolerance (GTT) were measured in the
mice.

Conclusions

Analysis
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Figure 3. GTT done at day 56 of dosing for the treatment
groups (Missing 60% TQ group).
Average blood glucose measurements in (mg/dL) taken at
various time points, after giving a oral dose of glucose (1
mg/kg).
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Male C57BL/6 mice that were 6
weeks of age were given a LFD
or HFD for 12 weeks

Mice dosed daily by
oral gavage

After 3 weeks, doses
were increased and
continued for 69 days

low fat diet (10% kcal, LFD)

high fat diet (60% kCal, HFD)

During the 12 week period,
body weight, FBG and GTT
were determined to assess
whether the HFD could
induce a diabetic condition

Dosed with Canola oil
Vehicle (CO, 5 ml/kg),

Dosed with CO (2.5
ml/kg),

Dosed with Rhein
(20 mg/kg in 5 ml/kg
CO)

Dosed with Rhein (50
mg/kg in 2.5 ml/kg CO)

Dosed with TQ (1
mg/kg, in 5 ml/kg CO

Dosed with TQ (10
mg/kg, in 2.5 ml/kg CO

Body
Bodyweight
weightand
andfood
foodconsumption
consumptionwere
weremeasured
measured daily.
daily.
At periodic
points
throughout
the study,
fasting
At periodic
points
throughout
the study,
fasting
FBG and
FBG and GTT were GTT
measured
were measured

Fasting Blood Glucose (FBG) and Glucose Tolerance Testing (GTT)
Mice were fasted overnight

The end of the mouse’s tail
was pricked and blood
was collected and
measured with a
glucometer twice.

Average of the two values
were recorded at initial
blood glucose and FBG

Mice were give a dose of
glucose (1g/kg) by oral
gavage.

At 15, 30, 60, and 90
minutes after the does of
glucose, mouse tail blood
was collected and
measured with the
glucometer twice and the
average of the two values
were recorded.

Preformed necropsy
and collected tissue
samples
Collected:
Blood,
Liver,
Kidneys,
Skeletal muscle,
Adipose tissue
Small intestine,
And colon

